Simulations Plus (NASDAQ:SLP) Releases FY 2026 Earnings Guidance

Simulations Plus (NASDAQ:SLP) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided earnings per share guidance of 1.030-1.100 for the period, compared to the consensus earnings per share estimate of 1.000. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $80.5 million.

Simulations Plus Stock Performance

Simulations Plus stock opened at $16.89 on Friday. Simulations Plus has a fifty-two week low of $12.39 and a fifty-two week high of $37.67. The stock has a market cap of $340.33 million, a price-to-earnings ratio of -5.28 and a beta of 1.09. The stock’s 50 day simple moving average is $19.04 and its two-hundred day simple moving average is $16.50.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.The business had revenue of $18.42 million during the quarter, compared to analysts’ expectations of $18.05 million. During the same period in the prior year, the company earned $0.17 earnings per share. On average, analysts predict that Simulations Plus will post 1.09 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SLP. Citigroup reiterated a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Zacks Research upgraded Simulations Plus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 28th. TD Cowen reissued a “hold” rating on shares of Simulations Plus in a report on Thursday, January 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. Finally, BTIG Research lowered shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research report on Thursday, December 18th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Simulations Plus presently has a consensus rating of “Hold” and a consensus price target of $25.00.

Institutional Trading of Simulations Plus

A number of institutional investors and hedge funds have recently bought and sold shares of SLP. Raymond James Financial Inc. bought a new position in Simulations Plus during the second quarter valued at $25,000. Quarry LP purchased a new stake in shares of Simulations Plus during the 3rd quarter valued at about $28,000. US Bancorp DE raised its position in shares of Simulations Plus by 32.5% during the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after buying an additional 1,513 shares in the last quarter. PharVision Advisers LLC purchased a new position in Simulations Plus in the third quarter worth about $155,000. Finally, First Trust Advisors LP purchased a new position in Simulations Plus in the third quarter worth about $167,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.